Linked Life Data

21310720

Source:http://linkedlifedata.com/resource/pubmed/id/21310720

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-4-18
pubmed:abstractText
Methylene blue-treated fresh-frozen plasma (MB-FFP) is mainly used in Europe. The advantage of the methylene blue system is that units can be treated individually. The combined action of methylene blue and illumination is a photodynamic process preventing viral RNA and DNA replication. We report the first immediate allergic hypersensitivity reaction to methylene blue-treated plasma transfusion. The clinical course and subsequent assessment of the allergic reaction, including skin tests and basophil activation test, confirmed methylene blue-induced IgE-mediated anaphylaxis. All immediate reactions after MB-FFP transfusion should be investigated to document the underlying mechanism.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1471-6771
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
687-9
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Anaphylactic reaction after methylene blue-treated plasma transfusion.
pubmed:affiliation
Assistance Publique Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Service d'Anesthésie-Réanimation & SAMU de Paris, 149 Rue de Sèvres, Paris, France. pascale.dewachter@yahoo.fr
pubmed:publicationType
Journal Article, Case Reports